{
    "ticker": "NXL",
    "name": "Nexalin Technology, Inc.",
    "description": "Nexalin Technology, Inc. is an innovative healthcare company focused on developing advanced treatment options for mental health disorders. Established in 2014, the company is dedicated to providing non-invasive and effective solutions that help individuals manage conditions such as anxiety, depression, and insomnia. Nexalin's flagship product is the Nexalin Device, which utilizes a proprietary technology combining low-frequency waveforms and electromagnetic fields to stimulate brain activity. This approach aims to restore balance in the brain's neurochemistry without the use of pharmaceuticals, offering a potential alternative to traditional treatments. The company\u2019s mission is to improve the quality of life for patients while reducing the reliance on medication, which often comes with side effects. Nexalin is committed to conducting rigorous clinical studies to validate the efficacy and safety of its technologies, ensuring that patients receive the highest standard of care. Through partnerships with healthcare providers and mental health professionals, Nexalin seeks to enhance awareness and accessibility of its treatment options. With a focus on innovation and patient-centered care, Nexalin Technology strives to lead the way in the future of mental health treatment.",
    "industry": [
        "Healthcare",
        "Medical Devices"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2014",
    "website": "http://www.nexalin.com",
    "ceo": "James A. H. Sweeney",
    "social_media": {
        "twitter": "https://twitter.com/Nexalin",
        "linkedin": "https://www.linkedin.com/company/nexalin-technology-inc/"
    },
    "investor_relations": "http://www.nexalin.com/investors",
    "key_executives": [
        {
            "name": "James A. H. Sweeney",
            "position": "CEO"
        },
        {
            "name": "Jeffrey K. Lee",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Mental Health Devices",
            "products": [
                "Nexalin Device"
            ]
        }
    ],
    "seo": {
        "meta_title": "Nexalin Technology, Inc. | Innovative Mental Health Solutions",
        "meta_description": "Explore Nexalin Technology, Inc., a leader in non-invasive mental health treatments. Learn about our innovative Nexalin Device and commitment to patient care.",
        "keywords": [
            "Nexalin",
            "Mental Health",
            "Innovative Treatment",
            "Non-invasive Therapy",
            "Healthcare Technology"
        ]
    },
    "faq": [
        {
            "question": "What is Nexalin Technology known for?",
            "answer": "Nexalin Technology is known for developing non-invasive treatment options for mental health disorders using advanced technology."
        },
        {
            "question": "Who is the CEO of Nexalin Technology?",
            "answer": "James A. H. Sweeney is the CEO of Nexalin Technology, Inc."
        },
        {
            "question": "Where is Nexalin Technology headquartered?",
            "answer": "Nexalin Technology is headquartered in San Diego, California, USA."
        },
        {
            "question": "What is the main product of Nexalin Technology?",
            "answer": "The main product of Nexalin Technology is the Nexalin Device, designed for mental health treatment."
        },
        {
            "question": "When was Nexalin Technology founded?",
            "answer": "Nexalin Technology was founded in 2014."
        }
    ],
    "competitors": [
        "MDGL",
        "AXSM",
        "HRTX",
        "AVXL"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRK",
        "ABBV"
    ]
}